garcinol has been researched along with Disease Exacerbation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Lawrence, L; Majeed, M; Majeed, S; Mundkur, L; Nagabhushanam, K | 1 |
Ji, J; Li, C; Li, L; Li, Z; Yang, T; Zhao, J | 1 |
2 other study(ies) available for garcinol and Disease Exacerbation
Article | Year |
---|---|
Novel Combinatorial Regimen of Garcinol and Curcuminoids for Non-alcoholic Steatohepatitis (NASH) in Mice.
Topics: Actins; Animals; Antioxidants; Diarylheptanoids; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Fatty Liver; Female; Fibrosis; Glutathione; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inflammation; Liver; Liver Cirrhosis; Malondialdehyde; Mice; Mice, Inbred C57BL; Muscle, Smooth; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Superoxide Dismutase; Terpenes; Triglycerides | 2020 |
Garcinol exerts anti-cancer effect in human cervical cancer cells through upregulation of T-cadherin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cadherins; Cell Line, Tumor; Disease Progression; Dose-Response Relationship, Drug; Female; Gene Knockdown Techniques; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; RNA, Small Interfering; Signal Transduction; Terpenes; Up-Regulation; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2018 |